The highest BARX2 level was observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), head and neck squamous cell carcinoma (HNSC) and kidney renal clear cell carcinoma (KIRC). This evidence concerns the gene BARX2 and head and neck squamous cell carcinoma.